ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 325268 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 325268; 2) Community: the network communities that were significantly associated with the response to NSC 325268; 3) Molecule: the relationships between components within communities and NSC 325268; 4) MDR: the compounds that were significantly associated with the NSC 325268.

NSC Compound Enrichment Correlation
NSC 733348 3-(4-Chlorobenzoyloxy)-7-(2-trifluoromethylphenyl)-1-hydroxy -2,4,8,9-tetrakis(methoxycarbonyl)bicyclo[3.3.1]non-3-ene 0.0145418727063286 0.0013691862
NSC 750717 5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one 0.0145418727063286 0.30104961
NSC 626876 2-Cyclopenten-1-one, 5-[(dimethylamino)methyl]-2-[2-[4- (2-methylpropyl)phenyl]propyl]-, hydrochloride 0.0149636429145595 0.42721383
NSC 662119 Null 0.0166986251090031 0.016129842
NSC 702616 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 4,5,6,7-tetrahydro- 0.0166986251090031 0.075504082
NSC 129518 Cyclopyrethrosin 0.0186186224062458 0.3324831
NSC 16258 Null 0.0186186224062458 0.37001953
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0186186224062458 0.32748994
NSC 222722 Null 0.0186186224062458 0.26367402
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0186186224062458 0.34091955
Total:90  Current:38    [First] [Prev] [Next] [Last]